KRYS
Krystal Biotech Inc
NASDAQ · Biotechnology
$272.74
+5.10 (+1.91%)
Performance
1D
—
1W
-3.38%
1M
+0.22%
3M
+34.35%
6M
+82.63%
1Y
+76.50%
YTD
+10.46%
Open$276.89
Previous Close$267.64
Day High$277.11
Day Low$260.03
52W High$295.98
52W Low$122.80
Volume313.3K
Avg Volume252.8K
Market Cap7.91B
P/E Ratio39.76
EPS$6.66
SectorBiotechnology
Volume Analysis
1.24x average volume
Technical Indicators
SMA 50
$254.29
Above
SMA 200
$182.21
Above
RSI (14)
41.2
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
18 analysts
Price Target
-68.2% upside
Current
$272.74
$272.74
Target
$86.77
$86.77
$54.31
$86.77 avg
$114.95
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 283.26M | 971.92M | 894.90M |
| Net Income | 86.93M | 120.52M | 102.54M |
| Profit Margin | 30.7% | 12.4% | 11.5% |
| EBITDA | 69.87M | 242.82M | 232.68M |
| Free Cash Flow | — | 82.52M | 69.44M |
| Rev Growth | — | +7.7% | -5.6% |
| Debt/Equity | — | 0.59 | 0.54 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |